Most recently, Dr Rogers has served as chief scientific officer and global head of Research and Development at Cordis Corporation
, a Johnson & Johnson company.
, part of the Johnson & Johnson family of companies, has launched a new ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal abdominal aortic aneurysms (AAA).
has launched SABER PTA Dilatation Catheter (SABER Catheter) for the treatment of patients with Peripheral Arterial Disease (PAD).
reported on Wednesday the receipt of approval for its latest guiding catheters, the ADROITTM 6F Guiding Catheter, from the Food and Drug Administration (FDA).
Key players in the peripheral vascular stents market include Abbott Vascular, Bard Peripheral Vascular, Biotronik, Boston Scientific, Cook Medical, Cordis Corporation
, Covidien, Medtronic and W.
, an interventional vascular technology company owned by Johnson & Johnson and based in Bridgewater, N.
com)-- ReportsandReports Announce it Will Carry Cordis Corporation
Market Share Analysis Market Research Report in its Store.
, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology.
That light bulb apparently went on over the head of someone working for Cordis Corporation
, maker of the Cypher heart stent.
, Miami, FL, a subsidiary of Johnson & Johnson, New Brunswick, NJ, received approval from the US Food and Drug Administration (FDA) to market its Cypher Sirolimus-eluting Coronary Stent to treat blocked coronary arteries.
US-based Cordis Corporation
, an interventional vascular technology company that forms part of Johnson & Johnson (NYSE:JNJ), revealed on Tuesday the launch of an agreement to acquire the exclusive distribution rights for the Chocolate PTA Balloon Catheter from TriReme Medical Inc.